Millipore Sigma Vibrant Logo

524735 Phosphodiesterase 11A1, Active, Human, Recombinant, S. frugiperda

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: PDE11A1, cAMP/cGMP cyclic nucleotide phosphodiesterase 11A1

524735
  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information
      Description
      Overview

      This product has been discontinued.





      Full-length, recombinant, human phosphodiesterase 11A1 expressed in S frugiperda insect cells using a baculovirus expression system. Supplied as a partially purified preparation.
      Catalogue Number524735
      Brand Family Calbiochem®
      SynonymsPDE11A1, cAMP/cGMP cyclic nucleotide phosphodiesterase 11A1
      Application Data
      Phosphodiesterase 11A1 was treated with increasing concentration of the inhibitor, Dipyridamole, and the activity assayed. the IC50 for this inhibition is 830 nM.
      References
      ReferencesGibson, L.C.D., et al. 2006. Eur. J. Pharmacol. 538, 39.
      Hetman, J.M., et al. 2000 Proc. Natl. Acad. Sci. USA 97, 12891.
      Product Information
      Activity≥0.5 units/µl
      Unit of DefinitionOne unit is defined as the amount of enzyme that will convert 1 pmole cAMP to AMP per min at pH 7.5, 30°C.
      FormLiquid
      FormulationIn 150 mM NaCl, 10 mM Tris, 0.1% NP-40, pH 8.3.
      Applications
      Biological Information
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      524735 0

      Documentation

      Referencias bibliográficas

      Visión general referencias
      Gibson, L.C.D., et al. 2006. Eur. J. Pharmacol. 538, 39.
      Hetman, J.M., et al. 2000 Proc. Natl. Acad. Sci. USA 97, 12891.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-November-2007 RFH
      SynonymsPDE11A1, cAMP/cGMP cyclic nucleotide phosphodiesterase 11A1
      Application Data
      Phosphodiesterase 11A1 was treated with increasing concentration of the inhibitor, Dipyridamole, and the activity assayed. the IC50 for this inhibition is 830 nM.
      DescriptionFull-length, recombinant, human phosphodiesterase 11A1 expressed in S frugiperda insect cells using a baculovirus expression system. Supplied as a partially purified preparation.
      FormLiquid
      FormulationIn 150 mM NaCl, 10 mM Tris, 0.1% NP-40, pH 8.3.
      Activity≥0.5 units/µl
      Unit definitionOne unit is defined as the amount of enzyme that will convert 1 pmole cAMP to AMP per min at pH 7.5, 30°C.
      Storage ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesGibson, L.C.D., et al. 2006. Eur. J. Pharmacol. 538, 39.
      Hetman, J.M., et al. 2000 Proc. Natl. Acad. Sci. USA 97, 12891.